在中国探索儿科医生的非标签处方行为:基于计划行为研究的理论
Yueqin Zhang1, Xuelin Sun2, Dong Wang3
1Department of Pharmacy, Beijing Aerospace General Hospital, Beijing, 100076, China.
International journal of clinical pharmacy
|October 29, 2025
概括
儿童非标签处方是由医生的意图驱动的,受到态度,控制信念和规范的影响. 解决这些因素并涉及药剂师的干预措施可以提高安全性和监督性.
科学领域:
- 儿科药理学 儿科药理学
- 医学中的行为科学.
- 卫生政策 卫生政策
背景情况:
- 由于缺乏儿科药物试验,非标签处方在儿科护理中很常见,这引发了安全性和疗效方面的担忧.
- 关于影响儿科医生非标签药物使用决定的行为因素的研究有限.
- 了解这些决定因素对于改善儿科患者安全和治疗结果至关重要.
研究的目的:
- 为了确定中国儿科医生非标药物使用的行为决定因素.
- 应用计划行为理论 (TPB) 来评估态度,主观规范和感知行为控制对处方意图和行为的影响.
- 为旨在优化儿科人口非标签处方实践的干预措施提供信息.
主要方法:
- 在中国40家医院的320名儿科医生中进行了横截面调查.
- 一个基于计划行为理论 (TPB) 的问卷被开发和验证.
- 使用结构方程建模 (SEM) 来分析TPB构造和规范行为之间的关系.
主要成果:
- 儿科医生承认非标签处方的必要性和风险.
- 态度 (感知到的好处,安全问题,成本) 和感知到的行为控制 (障碍如过时的标签,缺乏配方) 显著预测了意图.
- 行为意图是实际非标签处方行为的最强有力的预测因素;主观规范也影响了意图.
- 大多数儿科医生支持药剂师参与药物审查和监督.
结论:
- 中国的儿科非标签处方主要是由意图驱动的,受到态度,感知控制和专业规范的影响.
- 建议针对这些行为因素的干预措施,以及机构政策和药剂师合作.
- 通过多方面的方法,可以提高儿科护理中非标签药物使用的安全性,一致性和监管监督.
相关概念视频
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
189
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
189
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
251
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
251
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
240
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
240
01:08Obedience
35.2K
According to obedience research, we may harm others under the forceful pressures of an authority figure (Milgram, 1974). How about if the inappropriate orders were delivered with less force? The increasing interdependence between nurses and physicians compelled Hofling and his colleagues to explore nurses’ reactions to a potentially harmful medical request made by the perceived authority figure, the doctor (Hofling, Brotzman, Dalrymple, Graves, & Pierce, 1966). In this situation,...
35.2K
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
207
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
207
01:29Drug Dosing: Infants and Children
248
Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
248